Profil

Ternad Indiana

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chimie générale, organique et biomédicale

ORCID
0000-0002-7225-8807
Main Referenced Co-authors
LAURENT, Sophie  (30)
STANICKI, Dimitri  (29)
MULLER, Robert  (27)
VANGIJZEGEM, Thomas  (18)
BOUTRY, Sébastien  (15)
Main Referenced Keywords
[en] Alzheimer's disease (1); [en] LDLR (1); [en] molecular therapy (1); [en] peptides (1); [en] phospholipase A2 (1);
Main Referenced Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (21)
Main Referenced Disciplines
Chemistry (30)
Life sciences: Multidisciplinary, general & others (9)
Social & behavioral sciences, psychology: Multidisciplinary, general & others (1)

Publications (total 30)

The most downloaded
335 downloads
Stanicki, D., Vangijzegem, T., Ternad, I., & Laurent, S. (22 February 2022). An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery. Expert Opinion on Drug Delivery, 15, 1-15. doi:10.1080/17425247.2022.2047020 https://hdl.handle.net/20.500.12907/43263

The most cited

27 citations (Scopus®)

Stanicki, D., Vangijzegem, T., Ternad, I., & Laurent, S. (22 February 2022). An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery. Expert Opinion on Drug Delivery, 15, 1-15. doi:10.1080/17425247.2022.2047020 https://hdl.handle.net/20.500.12907/43263

Vangijzegem, T., Lecomte, V., Ternad, I., Van leuven, L., Muller, R., Stanicki, D., & Laurent, S. (2023). « Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy. Pharmaceutics. doi:10.3390/pharmaceutics15010236
Peer Reviewed verified by ORBi

Ternad, I., Penninckx, S., Lecomte, V., Vangijzegem, T., Conrard, L., Lucas, S., A.-C. Heuskin, Michiels, C., Muller, R., Stanicki, D., & Laurent, S. (2023). Advances in the Mechanistic Understanding of Iron Oxide Nanoparticles’ Radiosensitizing Properties. Nanomaterials.
Peer reviewed

Ternad, I., Penninckx, S., Lecomte, V., Vangijzegem, T., Garifo, S., L. Conrard, S. Lucas, A.-C. Heuskin, C. Michiels, Muller, R., Stanicki, D., & Laurent, S. (2023). Evaluation of Radiosensitizing Magnetic Nanoparticles as a Novel Theranostic Agent for Cancer Therapy [Poster presentation]. Poster communication presented at the European Molecular Imaging Meeting (EMIM 2023), 18th Annual Meeting of the European Society for Molecular Imaging, Salzburg, Austria.
Peer reviewed

Stanicki, D., Ternad, I., S. Penninckx, Muller, R., Vangijzegem, T., S. Lucas, C. Michiels, & Laurent, S. (2023). Advances in the mechanistic understanding of iron oxide nanoparticles’ radiosensitizing properties [Paper presentation]. EMRS 2023 Spring Meeting, 40th Anniversary Congress & Exhibition Centre, Strasbourg, France, France.
Peer reviewed

Ternad, I., Lecomte, V., Stanicki, D., Vangijzegem, T., S. Penninckx, Muller, R., Laurent, S., & S. Lucas. (2023). Magnetic nanoparticles as theranostic agents [Poster presentation]. EDT chim, UMONS, MONS, Belgique.
Peer reviewed

Lecomte, V., Ternad, I., Stanicki, D., & Laurent, S. (2023). Evaluation of Radiosensitizing Magnetic Nanoparticles as a novel Theranostic Agent for the Therapy of Cancer [Poster presentation]. SRC Young Chemists’ Day, Mons.
Peer reviewed

Lecomte, V., Ternad, I., Stanicki, D., Vangijzegem, T., S. Penninckx, Muller, R., Lucas, S., & Laurent, S. (2023). Radiosensitizing magnetic nanoparticles as a targeted theranostic agent for cancer therapy [Poster presentation]. 19eme édition de l’YBMRS, Blankenberge.
Peer reviewed

Ternad, I., Lecomte, V., Stanicki, D., Vangijzegem, T., Penninckx, S., Muller, R., Lucas, S., & Laurent, S. (18 October 2022). Iron oxide nanoparticles for theranostics applications [Poster presentation]. Journée scientifique de la Société Royale de Chimie.

Ternad, I., Stanicki, D., Vangijzegem, T., Boutry, S., Penninckx, S., Lecomte, V., Muller, R., Lucas, S., & Laurent, S. (06 September 2022). Magnetic nanoparticles for theranostics applications [Poster presentation]. Mardi des chercheurs, 11ème édition, Mons, Belgium.

Ternad, I., Stanicki, D., Vangijzegem, T., Penninckx, S., Muller, R., Lucas, S., & Laurent, S. (August 2022). PEGylated magnetic nanoparticles as a theranostic agent [Paper presentation]. Contrast Media Research Symposium, CMR 2022, Annapolis, United States.
Peer reviewed

Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Ternad, I., Muller, R., & Laurent, S. (August 2022). Preparation and characterizations of a Nanoplatform-based MRI/OI Contrast Agent [Paper presentation]. Contrast Media Research Symposium, CMR 2022, Annapolis, United States.
Peer reviewed

Ternad, I., Stanicki, D., Vangijzegem, T., Boutry, S., Penninckx, S., Lecomte, V., Muller, R., Lucas, S., & Laurent, S. (03 May 2022). PEGylated Magnetic Particles for MRI and Radiotherapy Application [Poster presentation]. Flash talk and poster session presented at BMIC-DyMIC Imaging Congress, Anvers, Belgium.
Peer reviewed

Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Ternad, I., Muller, R., & Laurent, S. (03 May 2022). Preparation, Characterizations and Imaging Study of a Nanometric Platform for Resonance and Fluorescence Imaging. Oral communication and poster session presented at BMIC-DyMIC Imaging Congress, Anvers, Belgium, 2, 1-2.
Peer reviewed

Stanicki, D., Vangijzegem, T., Ternad, I., & Laurent, S. (22 February 2022). An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery. Expert Opinion on Drug Delivery, 15, 1-15. doi:10.1080/17425247.2022.2047020
Peer Reviewed verified by ORBi

Ternad, I., Stanicki, D., Vangijzegem, T., Muller, R., & Laurent, S. (10 January 2022). PEGylated Iron oxide nanoparticles as a potential radiosensitizer [Paper presentation]. EDT-CHIM 2021 (20 mai), virtual meeting, .

Stanicki, D., Larbanoix, L., Boutry, S., Vangijzegem, T., Ternad, I., Garifo, S., Muller, R., & Laurent, S. (2021). Impact of the chain length on the biodistribution profiles of PEGylated iron oxide nanoparticles: a multimodal imaging study. Journal of Materials Chemistry.
Peer reviewed

Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Ternad, I., Muller, R., & Laurent, S. (24 November 2021). Functionalized silica nanoplatform as a bimodal contrast agent for MRI and optical imaging. Nanoscale, 13 (39), 16509 - 16524.
Peer reviewed

Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Ternad, I., Muller, R., & Laurent, S. (14 October 2021). Silica Nanoplatform for Multimodal Imaging: preparation and biodistribution studies [Poster presentation]. SRC, ULB, Bruxelles, Belgique, .

Ternad, I., Stanicki, D., Vangijzegem, T., Penninckx, S., Muller, R., Lucas, S., & Laurent, S. (14 October 2021). 'PEGylated magnetic nanoparticles for radiation therapy application [Poster presentation]. SRC, ULB, Bruxelles, Belgique, Bruxelles, Belgium.

Ternad, I., Stanicki, D., Vangijzegem, T., Penninckx, S., Muller, R., Lucas, S., & Laurent, S. (29 August 2021). Study of the radiosensitizing properties induced by PEGylated magnetic nanoparticles [Poster presentation]. 26th EFMC International Symposium on Medicinal Chemistry, EFMC-ISMC 2021, Virtual meeting, .

Garifo, S., Ternad, I., Vangijzegem, T., Stanicki, D., Boutry, S., Larbanoix, L., Muller, R., & Laurent, S. (07 June 2021). Preparation of a Silica Nanoplatform as Contrast Agent for MRI and Optical Imaging [Poster presentation]. Mardi des Chercheurs, Virtual Meeting, Unknown/unspecified.

Ternad, I., Stanicki, D., Vangijzegem, T., Muller, R., & Laurent, S. (30 March 2021). Study of the radiosensitizing properties induced by iron oxide nanoparticles [Poster presentation]. Mardi des Chercheurs, Virtual Meeting, Unknown/unspecified.

Stanicki, D., Larbanoix, L., Boutry, S., Vangijzegem, T., Ternad, I., Garifo, S., Muller, R., & Laurent, S. (2021). Impact of the chain length on the biodistribution profiles of PEGylated iron oxide nanoparticles: a multimodal imaging study. Journal of Materials Chemistry B.
Peer Reviewed verified by ORBi

Garifo, S., Ternad, I., Stanicki, D., Boutry, S., Larbanoix, L., Muller, R., & Laurent, S. (24 August 2020). Functionalized Silica Nanoplatform as Bimodal Contrast Agent for MRI and Optical Imaging [Poster presentation]. 15th European Molecular Imaging Meeting (ESMI) - Virtual Meeting, Gottingen , Germany.

Ternad, I., Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Muller, R., & Laurent, S. (10 December 2019). Silica Nanoplatform as Bimodal Contrast Agent for 1H MRI and Optical Imaging [Poster presentation]. SF Nano - C Nano Joint Meeting, Dijon, France.

Ternad, I., Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Muller, R., & Laurent, S. (10 December 2019). Silica Nanoplatforms as Bimodal Contrast Agents for 1H MRI and Optical Imaging [Poster presentation]. SF Nano - C Nano Joint Meeting, Dijon, France.

Ternad, I., Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Muller, R., & Laurent, S. (01 November 2019). Development of silica nanoparticles for 1H MRI and optical imaging [Poster presentation]. 5th International Electronic Conference on Medicinal Chemistry ECMC-5, Bruxelles, Belgium.

Garifo, S., Ternad, I., Stanicki, D., Boutry, S., Larbanoix, L., Muller, R., & Laurent, S. (10 October 2019). Functionalized Silica Nanoplatform as bimodal Contrast Agent for 1H MRI and optical imaging [Poster presentation]. SRC Scientific Day, Namur, Belgium.

Ternad, I., & Laurent, S. (2019). Mise au point d'une plateforme nanoparticulaire fluorescente en tant qu'agent de contraste pour l'imagerie optique et photoacoustique [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/27797

Ternad, I., Garifo, S., Stanicki, D., Boutry, S., Larbanoix, L., Muller, R., & Laurent, S. (29 January 2019). Development of silica Nanoplatforms as Bimodal Contrast Agent [Poster presentation]. Nanomaterials Applied to Life Sciences 2020 (NALS 2020), Madrid, Spain.

Contact ORBi UMONS